Literature DB >> 22475815

Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.

V Pauly1, V Pradel, L Pourcel, S Nordmann, E Frauger, M Lapeyre-Mestre, J Micallef, X Thirion.   

Abstract

INTRODUCTION: Prescription drug abuse is a major concern in several countries. France appears to be particularly prone to the abuse of opiate maintenance treatment (OMT) opioids and benzodiazepines (BZD), whereas the abuse of opioid analgesics (OA) is less commonly reported. To estimate the extent of psychoactive drug abuse, the French drug agency relies on different methods measuring various diversion indicators used as proxies for the detection of abuse/misuse: suspicion of abuse/dependence, illegal acquisition by patients seen in specialized care centers, prescription forgery and doctor shopping. The main objectives of the present study are to analyse the abuse and diversion of opioids (both OA and OMT), in comparison with those of BZDs, through the concurrent use of three different data sources.
METHODS: Diversion and abuse of opioids were analysed using indicators of abuse and diversion derived from three data sources over the period 2006-2008. Then, opioids were compared to BZDs for the year 2008 using the same indicators.
RESULTS: The analysis suggests that BZDs are more commonly dispensed than OAs and OMTs but that abuse and diversion are related mainly to OMT (particularly to buprenorphine), morphine and BZDs and less to OAs (except for morphine).
CONCLUSION: This study presents an original approach, based on the use of multiple data sources, to evaluate and compare the estimated abuse and diversion of opioids and benzodiazepines. It provides health authorities with a global, comparative and summarized overall view of the importance of different patterns of diversion and abuse for different prescription drugs.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475815     DOI: 10.1016/j.drugalcdep.2012.03.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  10 in total

Review 1.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

2.  Detection of signals of abuse and dependence applying disproportionality analysis.

Authors:  V Pauly; M Lapeyre-Mestre; D Braunstein; M Rueter; X Thirion; E Jouanjus; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2014-11-20       Impact factor: 2.953

3.  Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Authors:  Damien Driot; Emilie Jouanjus; Stéphane Oustric; Julie Dupouy; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

4.  Buprenorphine treatment for narcotic addiction: not without risks.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

5.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

6.  Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter".

Authors:  Emilie Jouanjus; Michel Mallaret; Joëlle Micallef; Camille Ponté; Anne Roussin; Maryse Lapeyre-Mestre
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

7.  Patterns and profiles of methylphenidate use both in children and adults.

Authors:  Vanessa Pauly; Elisabeth Frauger; Magalie Lepelley; Michel Mallaret; Quentin Boucherie; Joëlle Micallef
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

8.  A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019).

Authors:  Joelle Perri-Plandé; Ghada Miremont-Salamé; Joëlle Micallef; Cameron Herman; Marie Baumevieille; Frédéric Abriat; Maryse Lapeyre-Mestre; Françoise Haramburu; Amélie Daveluy
Journal:  Drug Saf       Date:  2021-10-29       Impact factor: 5.606

9.  French Experience with Buprenorphine : Do Physicians Follow the Guidelines?

Authors:  Morgane Guillou Landreat; Charles Rozaire; Jean Yves Guillet; Caroline Victorri Vigneau; Jean Yves Le Reste; Marie Grall Bronnec
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

10.  The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users.

Authors:  Amine Benyamina
Journal:  Int J Gen Med       Date:  2014-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.